Evidence map›Paper›PMID 35916123›Full record

ArticleAllergy2022

Fel d 1 surface expression on plant-made eBioparticles combines potent immune activation and hypoallergenicity.

Stefanie Busold, Lorenz Aglas, Charlotte Menage, Lydia Auger, Réjean Desgagnés, Loïc Faye, Anne-Catherine Fitchette, Esther C de Jong, Caroline Martel, Maria Stigler and 6 more

Abstract readLetter
In one paragraph

Article in Allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Allergy to Cats: Current Perspectives and Therapeutic Options.Clinical and translational allergy · 2026
    Review
  4. Review
  5. Next-Generation Allergen-Specific Immunotherapy for Food Allergy.Clinical reviews in allergy & immunology · 2025
    Review
  6. Article
  7. Article
  8. Plant-based enveloped Ara h 2 bioparticles display exceptional hypo-allergenicity.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Stefanie BusoldDepartment of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-2879-5074
Lorenz AglasDepartment of Biosciences and Medical Biology, Paris Lodron University of Salzburg, Salzburg, Austria.
Charlotte MenageDepartment of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Lydia AugerAngany Inc., Québec, Québec, Canada.
Réjean DesgagnésAngany Inc., Québec, Québec, Canada.
Loïc FayeAngany Innovation, Val-de-Reuil, France.
Anne-Catherine FitchetteAngany Innovation, Val-de-Reuil, France.
Esther C de JongDepartment of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Caroline MartelAngany Inc., Québec, Québec, Canada.
Maria StiglerDepartment of Biosciences and Medical Biology, Paris Lodron University of Salzburg, Salzburg, Austria.
Virginie Catala-StordeurAngany Innovation, Val-de-Reuil, France.
Guy TropperAngany Inc., Québec, Québec, Canada.
Louis-Philippe VézinaAngany Inc., Québec, Québec, Canada.
Véronique GomordAngany Innovation, Val-de-Reuil, France.
Teunis B H GeijtenbeekDepartment of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Ronald van ReeDepartment of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.

Funding

Austrian Science Fund FWF
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllergensImmunoglobulin EHumansAllergensImmunoglobulin E

Identifiers

PMID35916123
PMCPMC10286754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.